{"id":45553,"date":"2025-11-03T11:03:30","date_gmt":"2025-11-03T03:03:30","guid":{"rendered":"https:\/\/flcube.com\/?p=45553"},"modified":"2025-11-03T11:03:31","modified_gmt":"2025-11-03T03:03:31","slug":"lepus-minwei-licenses-mwn105-injection-to-denmarks-sidera-bio-up-to-1-01-b-in-milestones","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=45553","title":{"rendered":"Lepu\u2019s Minwei Licenses MWN105 Injection to Denmark\u2019s Sidera Bio, Up to $1.01\u202fB in Milestones"},"content":{"rendered":"\n<p><strong>Lepu (Beijing) Medical Technology Co., Ltd.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/300003:SHE\">SHE: 300003<\/a>) announced that its wholly\u2011owned subsidiary <strong>Shanghai Minwei Biotechnology Co., Ltd.<\/strong> has entered into an exclusive licensing agreement with <strong>Sidera Bio Aps.<\/strong> (Denmark) for the triple\u2011receptor agonist <strong>MWN105 injection<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-deal-overview\">Deal Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Details<\/th><\/tr><\/thead><tbody><tr><td><strong>Licensee<\/strong><\/td><td>Sidera Bio (Denmark) \u2013 exclusive global rights <strong>outside Greater China<\/strong> (Mainland China, Hong Kong SAR, Macau SAR, Taiwan)<\/td><\/tr><tr><td><strong>Up\u2011front &amp; Near\u2011Term Payments<\/strong><\/td><td>$35\u202fmillion (initial investment + early milestones)<\/td><\/tr><tr><td><strong>Cumulative Milestones<\/strong><\/td><td>Up to <strong>$1.01\u202fbillion<\/strong> tied to clinical\u2011development milestones and commercial\u2011sales thresholds<\/td><\/tr><tr><td><strong>Equity Component<\/strong><\/td><td>Minwei to acquire a <strong>9.99\u202f%<\/strong> stake in Sidera Bio<\/td><\/tr><tr><td><strong>Royalty Structure<\/strong><\/td><td>Tiered royalties on net annual sales in licensed territories<\/td><\/tr><tr><td><strong>Product<\/strong><\/td><td>MWN105 injection \u2013 GLP\u20111\/GIP\/FGF21 triple receptor agonist for diabetes, obesity &amp; metabolic disease<\/td><\/tr><tr><td><strong>Regulatory Status<\/strong><\/td><td>Approved in Mainland China; ongoing Phase\u202fII\/III trials in China<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-rationale\">Strategic Rationale<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Global Reach<\/strong> \u2013 Sidera Bio gains a platform\u2011class asset with a clear path to markets in Europe, the U.S., and emerging economies, while Lepu\/Minwei retains rights in the high\u2011growth Greater China region.<\/li>\n\n\n\n<li><strong>Financial Upside<\/strong> \u2013 The $35\u202fM upfront and $1.01\u202fB potential milestone structure provide significant upside for Minwei and, by extension, Lepu shareholders.<\/li>\n\n\n\n<li><strong>Portfolio Synergy<\/strong> \u2013 MWN105\u2019s triple\u2011agonist mechanism complements Sidera\u2019s existing pipeline in metabolic disorders, accelerating time\u2011to\u2011market for a differentiated therapy.<\/li>\n\n\n\n<li><strong>Equity Alignment<\/strong> \u2013 The 9.99\u202f% equity stake aligns long\u2011term interests of both parties and offers Minwei exposure to Sidera\u2019s future valuation.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-about-mwn105\">About MWN105<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Mechanism<\/strong>: Simultaneous activation of GLP\u20111, GIP, and FGF21 receptors, targeting glucose regulation, appetite control, and lipid metabolism.<\/li>\n\n\n\n<li><strong>Indications<\/strong>: Type\u202f2 diabetes, obesity, and broader metabolic disease spectrum.<\/li>\n\n\n\n<li><strong>Clinical Progress<\/strong>: Completed Phase\u202fII in China with positive efficacy and safety signals; Phase\u202fIII enrollment underway.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-about-the-companies\">About the Companies<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Lepu (Beijing) Medical Technology Co., Ltd.<\/strong> \u2013 A leading Chinese integrated medical\u2011device and pharmaceutical group, listed on the Shenzhen Stock Exchange (SHE: 300003).<\/li>\n\n\n\n<li><strong>Shanghai Minwei Biotechnology Co., Ltd.<\/strong> \u2013 Lepu\u2019s biotech arm focused on innovative peptide\u2011based therapeutics.<\/li>\n\n\n\n<li><strong>Sidera Bio A\/S<\/strong> \u2013 Denmark\u2011based biopharma specializing in metabolic\u2011disease drug development, with a robust global commercialization platform.<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This release contains forward\u2011looking statements that involve risks and uncertainties, including assumptions about regulatory approvals, clinical trial outcomes, and market acceptance. Actual results may differ materially.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lepu (Beijing) Medical Technology Co., Ltd. (SHE: 300003) announced that its wholly\u2011owned subsidiary Shanghai Minwei&#8230;<\/p>\n","protected":false},"author":1,"featured_media":45554,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[39,4361,374,2169,86,864],"class_list":["post-45553","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-diabetes","tag-hot-targets","tag-lepu-medical-technology","tag-minwei-biotechnology","tag-obesity","tag-she-300003"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Lepu\u2019s Minwei Licenses MWN105 Injection to Denmark\u2019s Sidera Bio, Up to $1.01\u202fB in Milestones - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Lepu (Beijing) Medical Technology Co., Ltd. (SHE: 300003) announced that its wholly\u2011owned subsidiary Shanghai Minwei Biotechnology Co., Ltd. has entered into an exclusive licensing agreement with Sidera Bio Aps. (Denmark) for the triple\u2011receptor agonist MWN105 injection.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=45553\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lepu\u2019s Minwei Licenses MWN105 Injection to Denmark\u2019s Sidera Bio, Up to $1.01\u202fB in Milestones\" \/>\n<meta property=\"og:description\" content=\"Lepu (Beijing) Medical Technology Co., Ltd. (SHE: 300003) announced that its wholly\u2011owned subsidiary Shanghai Minwei Biotechnology Co., Ltd. has entered into an exclusive licensing agreement with Sidera Bio Aps. (Denmark) for the triple\u2011receptor agonist MWN105 injection.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=45553\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-03T03:03:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-03T03:03:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0301.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45553#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45553\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Lepu\u2019s Minwei Licenses MWN105 Injection to Denmark\u2019s Sidera Bio, Up to $1.01\u202fB in Milestones\",\"datePublished\":\"2025-11-03T03:03:30+00:00\",\"dateModified\":\"2025-11-03T03:03:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45553\"},\"wordCount\":388,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45553#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0301.webp\",\"keywords\":[\"Diabetes\",\"Hot targets\",\"Lepu Medical Technology\",\"Minwei Biotechnology\",\"Obesity\",\"SHE: 300003\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=45553#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45553\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=45553\",\"name\":\"Lepu\u2019s Minwei Licenses MWN105 Injection to Denmark\u2019s Sidera Bio, Up to $1.01\u202fB in Milestones - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45553#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45553#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0301.webp\",\"datePublished\":\"2025-11-03T03:03:30+00:00\",\"dateModified\":\"2025-11-03T03:03:31+00:00\",\"description\":\"Lepu (Beijing) Medical Technology Co., Ltd. (SHE: 300003) announced that its wholly\u2011owned subsidiary Shanghai Minwei Biotechnology Co., Ltd. has entered into an exclusive licensing agreement with Sidera Bio Aps. (Denmark) for the triple\u2011receptor agonist MWN105 injection.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45553#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=45553\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45553#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0301.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0301.webp\",\"width\":1080,\"height\":608,\"caption\":\"Lepu\u2019s Minwei Licenses MWN105 Injection to Denmark\u2019s Sidera Bio, Up to $1.01\u202fB in Milestones\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45553#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lepu\u2019s Minwei Licenses MWN105 Injection to Denmark\u2019s Sidera Bio, Up to $1.01\u202fB in Milestones\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Lepu\u2019s Minwei Licenses MWN105 Injection to Denmark\u2019s Sidera Bio, Up to $1.01\u202fB in Milestones - Insight, China&#039;s Pharmaceutical Industry","description":"Lepu (Beijing) Medical Technology Co., Ltd. (SHE: 300003) announced that its wholly\u2011owned subsidiary Shanghai Minwei Biotechnology Co., Ltd. has entered into an exclusive licensing agreement with Sidera Bio Aps. (Denmark) for the triple\u2011receptor agonist MWN105 injection.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=45553","og_locale":"en_US","og_type":"article","og_title":"Lepu\u2019s Minwei Licenses MWN105 Injection to Denmark\u2019s Sidera Bio, Up to $1.01\u202fB in Milestones","og_description":"Lepu (Beijing) Medical Technology Co., Ltd. (SHE: 300003) announced that its wholly\u2011owned subsidiary Shanghai Minwei Biotechnology Co., Ltd. has entered into an exclusive licensing agreement with Sidera Bio Aps. (Denmark) for the triple\u2011receptor agonist MWN105 injection.","og_url":"https:\/\/flcube.com\/?p=45553","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-11-03T03:03:30+00:00","article_modified_time":"2025-11-03T03:03:31+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0301.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=45553#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=45553"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Lepu\u2019s Minwei Licenses MWN105 Injection to Denmark\u2019s Sidera Bio, Up to $1.01\u202fB in Milestones","datePublished":"2025-11-03T03:03:30+00:00","dateModified":"2025-11-03T03:03:31+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=45553"},"wordCount":388,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=45553#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0301.webp","keywords":["Diabetes","Hot targets","Lepu Medical Technology","Minwei Biotechnology","Obesity","SHE: 300003"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=45553#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=45553","url":"https:\/\/flcube.com\/?p=45553","name":"Lepu\u2019s Minwei Licenses MWN105 Injection to Denmark\u2019s Sidera Bio, Up to $1.01\u202fB in Milestones - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=45553#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=45553#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0301.webp","datePublished":"2025-11-03T03:03:30+00:00","dateModified":"2025-11-03T03:03:31+00:00","description":"Lepu (Beijing) Medical Technology Co., Ltd. (SHE: 300003) announced that its wholly\u2011owned subsidiary Shanghai Minwei Biotechnology Co., Ltd. has entered into an exclusive licensing agreement with Sidera Bio Aps. (Denmark) for the triple\u2011receptor agonist MWN105 injection.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=45553#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=45553"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=45553#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0301.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0301.webp","width":1080,"height":608,"caption":"Lepu\u2019s Minwei Licenses MWN105 Injection to Denmark\u2019s Sidera Bio, Up to $1.01\u202fB in Milestones"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=45553#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Lepu\u2019s Minwei Licenses MWN105 Injection to Denmark\u2019s Sidera Bio, Up to $1.01\u202fB in Milestones"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0301.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45553","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=45553"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45553\/revisions"}],"predecessor-version":[{"id":45555,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45553\/revisions\/45555"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/45554"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=45553"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=45553"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=45553"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}